Infection

This category deals with new developments in the field of infection imaging, covering the development of pathogen-specific molecular imaging agents in preclinical, translational, and clinical settings. This category also includes molecular imaging of the host response to specific infectious etiologies, the use of molecular imaging agents to assess antimicrobial drug pharmacokinetics, as well as the development and implementation of novel infection imaging agents/technologies and their translation to clinical practice.

Probes & Targets

The design, chemical synthesis and characterization of imaging probes or reporter genes and their targets prior to in vivo applications. Research targeting new biological mechanisms where imaging is used as a tool to gain mechanistic insights into disease are included. All imaging modalities covered.

Preclinical Imaging

All applications were new imaging tools and probes as well as the repurposing of existing ones, are evaluated in preclinical models of infection and infection-mediated host response.

Translational and Human Studies

Research on humans or (non-human) studies with demonstrated potential for clinical impact or immediate translation should be submitted to this category. It includes prospective and retrospective studies as well as studies on new pharmaceuticals at phase I-IV where imaging plays a significant role in the study. Studies on Omics and its combination with imaging are also welcome.

Image-guided Therapy and Theranostics

Research encompassing the theranostic repurposing of existing molecular imaging probes, applications where imaging is used for treatment planning and/or monitoring treatment response, and innovative strategies that integrate molecular imaging with conventional therapies. It also includes preclinical testing of theranostic agents and their translational applications in humans, including real-time monitoring of treatment responses to infections and infection-mediated host responses.